Literature DB >> 17213214

Cohort profile: the North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD).

Stephen J Gange1, Mari M Kitahata, Michael S Saag, David R Bangsberg, Ronald J Bosch, John T Brooks, Liviana Calzavara, Steven G Deeks, Joseph J Eron, Kelly A Gebo, M John Gill, David W Haas, Robert S Hogg, Michael A Horberg, Lisa P Jacobson, Amy C Justice, Gregory D Kirk, Marina B Klein, Jeffrey N Martin, Rosemary G McKaig, Benigno Rodriguez, Sean B Rourke, Timothy R Sterling, Aimee M Freeman, Richard D Moore.   

Abstract

Entities:  

Mesh：

Year:  2007        PMID： 17213214      PMCID： PMC2820873          DOI： 10.1093/ije/dyl286

Source DB:  PubMed          Journal:  Int J Epidemiol        ISSN： 0300-5771            Impact factor:   7.196


× No keyword cloud information.
  10 in total

1.  Explaining variability in the relationship between antiretroviral adherence and HIV mutation accumulation.

Authors:  R S Braithwaite; S Shechter; M S Roberts; A Schaefer; D R Bangsberg; P R Harrigan; A C Justice
Journal:  J Antimicrob Chemother       Date:  2006-10-05       Impact factor: 5.790

2.  Individual variation in CD4 cell count trajectory among human immunodeficiency virus-infected men and women on long-term highly active antiretroviral therapy: an application using a Bayesian random change-point model.

Authors:  Haitao Chu; Stephen J Gange; Traci E Yamashita; Donald R Hoover; Joan S Chmiel; Joseph B Margolick; Lisa P Jacobson
Journal:  Am J Epidemiol       Date:  2005-08-31       Impact factor: 4.897

3.  Association of race and gender with HIV-1 RNA levels and immunologic progression.

Authors:  K Anastos; S J Gange; B Lau; B Weiser; R Detels; J V Giorgi; J B Margolick; M Cohen; J Phair; S Melnick; C R Rinaldo; A Kovacs; A Levine; S Landesman; M Young; A Muñoz; R M Greenblatt
Journal:  J Acquir Immune Defic Syndr       Date:  2000-07-01       Impact factor: 3.731

4.  Predictive value of plasma HIV RNA level on rate of CD4 T-cell decline in untreated HIV infection.

Authors:  Benigno Rodríguez; Ajay K Sethi; Vinay K Cheruvu; Wilma Mackay; Ronald J Bosch; Mari Kitahata; Stephen L Boswell; W Christopher Mathews; David R Bangsberg; Jeffrey Martin; Christopher C Whalen; Scott Sieg; Suhrida Yadavalli; Steven G Deeks; Michael M Lederman
Journal:  JAMA       Date:  2006-09-27       Impact factor: 56.272

5.  Patterns of the hazard of death after AIDS through the evolution of antiretroviral therapy: 1984-2004.

Authors:  Michael F Schneider; Stephen J Gange; Carolyn M Williams; Kathryn Anastos; Ruth M Greenblatt; Lawrence Kingsley; Roger Detels; Alvaro Muñoz
Journal:  AIDS       Date:  2005-11-18       Impact factor: 4.177

6.  Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene. Hemophilia Growth and Development Study, Multicenter AIDS Cohort Study, Multicenter Hemophilia Cohort Study, San Francisco City Cohort, ALIVE Study.

Authors:  M Dean; M Carrington; C Winkler; G A Huttley; M W Smith; R Allikmets; J J Goedert; S P Buchbinder; E Vittinghoff; E Gomperts; S Donfield; D Vlahov; R Kaslow; A Saah; C Rinaldo; R Detels; S J O'Brien
Journal:  Science       Date:  1996-09-27       Impact factor: 47.728

Review 7.  HIV treatment response and prognosis in Europe and North America in the first decade of highly active antiretroviral therapy: a collaborative analysis.

Authors:  Margaret T May; Jonathan A C Sterne; Dominique Costagliola; Caroline A Sabin; Andrew N Phillips; Amy C Justice; François Dabis; John Gill; Jens Lundgren; Robert S Hogg; Frank de Wolf; Gerd Fätkenheuer; Schlomo Staszewski; Antonella d'Arminio Monforte; Matthias Egger
Journal:  Lancet       Date:  2006-08-05       Impact factor: 79.321

8.  Predictors of trend in CD4-positive T-cell count and mortality among HIV-1-infected individuals with virological failure to all three antiretroviral-drug classes.

Authors:  Bruno Ledergerber; Jens D Lundgren; A Sarah Walker; Caroline Sabin; Amy Justice; Peter Reiss; Cristina Mussini; Ferdinand Wit; Antonella d'Arminio Monforte; Rainer Weber; Gregory Fusco; Schlomo Staszewski; Matthew Law; Robert Hogg; Fiona Lampe; M John Gill; Francesco Castelli; Andrew N Phillips
Journal:  Lancet       Date:  2004 Jul 3-9       Impact factor: 79.321

9.  Mortality of HIV-1-infected patients in the first year of antiretroviral therapy: comparison between low-income and high-income countries.

Authors:  Paula Braitstein; Martin W G Brinkhof; François Dabis; Mauro Schechter; Andrew Boulle; Paolo Miotti; Robin Wood; Christian Laurent; Eduardo Sprinz; Catherine Seyler; David R Bangsberg; Eric Balestre; Jonathan A C Sterne; Margaret May; Matthias Egger
Journal:  Lancet       Date:  2006-03-11       Impact factor: 79.321

10.  Injection drug use and patterns of highly active antiretroviral therapy use: an analysis of ALIVE, WIHS, and MACS cohorts.

Authors:  John D Morris; Elizabeth T Golub; Shruti H Mehta; Lisa P Jacobson; Stephen J Gange
Journal:  AIDS Res Ther       Date:  2007-06-06       Impact factor: 2.250
  10 in total
  125 in total

1.  Missing data on the estimation of the prevalence of accumulated human immunodeficiency virus drug resistance in patients treated with antiretroviral drugs in north america.

Authors:  Alison G Abraham; Bryan Lau; Steven Deeks; Richard D Moore; Jinbing Zhang; Joseph Eron; Richard Harrigan; M John Gill; Mari Kitahata; Marina Klein; Sonia Napravnik; Anita Rachlis; Benigno Rodriguez; Sean Rourke; Constance Benson; Ron Bosch; Ann Collier; Kelly Gebo; James Goedert; Robert Hogg; Michael Horberg; Lisa Jacobson; Amy Justice; Greg Kirk; Jeff Martin; Rosemary McKaig; Michael Silverberg; Timothy Sterling; Jennifer Thorne; James Willig; Stephen J Gange
Journal:  Am J Epidemiol       Date:  2011-08-03       Impact factor: 4.897

2.  A Comparison of Seven Cox Regression-Based Models to Account for Heterogeneity Across Multiple HIV Treatment Cohorts in Latin America and the Caribbean.

Authors:  Mark J Giganti; Paula M Luz; Yanink Caro-Vega; Carina Cesar; Denis Padgett; Serena Koenig; Juan Echevarria; Catherine C McGowan; Bryan E Shepherd
Journal:  AIDS Res Hum Retroviruses       Date:  2015-03-06       Impact factor: 2.205

3.  Determinants of Liver Complications Among HIV/Hepatitis B Virus-Coinfected Patients.

Authors:  Vincent Lo Re; Craig W Newcomb; Dena M Carbonari; Jason A Roy; Keri N Althoff; Mari M Kitahata; K Rajender Reddy; Joseph K Lim; Michael J Silverberg; Angel M Mayor; Michael A Horberg; Edward R Cachay; Gregory D Kirk; Mark Hull; John Gill; Timothy R Sterling; Jay R Kostman; Marion G Peters; Richard D Moore; Marina B Klein; H Nina Kim
Journal:  J Acquir Immune Defic Syndr       Date:  2019-09-01       Impact factor: 3.731

4.  Incidence of AIDS-defining and Other Cancers in HIV-positive Children in South Africa: Record Linkage Study.

Authors:  Julia Bohlius; Nicola Maxwell; Adrian Spoerri; Rosalind Wainwright; Shobna Sawry; Janet Poole; Brian Eley; Hans Prozesky; Helena Rabie; Daniela Garone; Karl-Günter Technau; Mhairi Maskew; Mary-Ann Davies; Alan Davidson; D Cristina Stefan; Matthias Egger
Journal:  Pediatr Infect Dis J       Date:  2016-06       Impact factor: 2.129

5.  Cohort Profile: the international epidemiological databases to evaluate AIDS (IeDEA) in sub-Saharan Africa.

Authors:  Matthias Egger; Didier K Ekouevi; Carolyn Williams; Rita Elias Lyamuya; Henri Mukumbi; Paula Braitstein; Tyler Hartwell; Claire Graber; Benjamin H Chi; Andrew Boulle; François Dabis; Kara Wools-Kaloustian
Journal:  Int J Epidemiol       Date:  2011-05-18       Impact factor: 7.196

6.  Invasive cervical cancer risk among HIV-infected women: a North American multicohort collaboration prospective study.

Authors:  Alison G Abraham; Gypsyamber D'Souza; Yuezhou Jing; Stephen J Gange; Timothy R Sterling; Michael J Silverberg; Michael S Saag; Sean B Rourke; Anita Rachlis; Sonia Napravnik; Richard D Moore; Marina B Klein; Mari M Kitahata; Gregory D Kirk; Robert S Hogg; Nancy A Hessol; James J Goedert; M John Gill; Kelly A Gebo; Joseph J Eron; Eric A Engels; Robert Dubrow; Heidi M Crane; John T Brooks; Ronald J Bosch; Howard D Strickler
Journal:  J Acquir Immune Defic Syndr       Date:  2013-04-01       Impact factor: 3.731

7.  Retention among North American HIV-infected persons in clinical care, 2000-2008.

Authors:  Peter Rebeiro; Keri N Althoff; Kate Buchacz; John Gill; Michael Horberg; Hartmut Krentz; Richard Moore; Timothy R Sterling; John T Brooks; Kelly A Gebo; Robert Hogg; Marina Klein; Jeffrey Martin; Michael Mugavero; Sean Rourke; Michael J Silverberg; Jennifer Thorne; Stephen J Gange
Journal:  J Acquir Immune Defic Syndr       Date:  2013-03-01       Impact factor: 3.731

8.  Disparities in the quality of HIV care when using US Department of Health and Human Services indicators.

Authors:  Keri N Althoff; Peter Rebeiro; John T Brooks; Kate Buchacz; Kelly Gebo; Jeffrey Martin; Robert Hogg; Jennifer E Thorne; Marina Klein; M John Gill; Timothy R Sterling; Baligh Yehia; Michael J Silverberg; Heidi Crane; Amy C Justice; Stephen J Gange; Richard Moore; Mari M Kitahata; Michael A Horberg
Journal:  Clin Infect Dis       Date:  2014-01-23       Impact factor: 9.079

9.  Laboratory Measures as Proxies for Primary Care Encounters: Implications for Quantifying Clinical Retention Among HIV-Infected Adults in North America.

Authors:  Peter F Rebeiro; Keri N Althoff; Bryan Lau; John Gill; Alison G Abraham; Michael A Horberg; Mari M Kitahata; Baligh R Yehia; Hasina Samji; John T Brooks; Kate Buchacz; Sonia Napravnik; Michael J Silverberg; Anita Rachlis; Kelly A Gebo; Timothy R Sterling; Richard D Moore; Stephen J Gange
Journal:  Am J Epidemiol       Date:  2015-11-17       Impact factor: 4.897

10.  Adjusting mortality for loss to follow-up: analysis of five ART programmes in sub-Saharan Africa.

Authors:  Martin W G Brinkhof; Ben D Spycher; Constantin Yiannoutsos; Ralf Weigel; Robin Wood; Eugène Messou; Andrew Boulle; Matthias Egger; Jonathan A C Sterne
Journal:  PLoS One       Date:  2010-11-30       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.